WASE secures investment from Science Angel Syndicate

WASE, a modular bioenergy production and wastewater treatment company based in London, UK, have secured a £1m Seed funding round.

The funding will be used to accelerate the commercialisation of their technology to help the food and drinks industry become net carbon neutral.

Science Angel Syndicate invested alongside lead investor Elbow Beach Capital, a newly established private investment company focused on sustainable energy, transition technology and social impact business.

WASE were successful in completing their round from crowdfunding platform Seedrs.

WASE has developed a modular waste to energy solution for food and drink manufacturers called industriWASE. The investment will allow the company to begin paid pilot trials with customers in the brewing sector.

SME breweries face a unique challenge to become net carbon neutral and WASE believe their modular approach ensures customers have the optimal waste treatment capacity on site.

Beyond the food and beverage industry, globally, 80% of wastewater is discharged untreated into the environment. This is the equivalent to 2.5 million Olympic pools of wastewater polluting the planet every day.

Dr Thomas Fudge, CEO of WASE said: “To tackle the growing issues of pollution, climate change and the energy crisis we need to implement new approaches now to create a sustainable future. We are scaling up our work with SME food and drink manufacturers to provide decentralised solutions. Allowing our customers to treat waste where it is produced and generate bioenergy, fertilisers and recover water. Together we will grow our work so that we can create flourishing communities.”

Dr Ben Miles, co-founder of Science Angel Syndicate, said: “The WASE technology represents a step change in overcoming many of the limitations of previous approaches to bioenergy production. We were exceptionally impressed by the expertise of the WASE team and believe they will have a great impact in helping to decarbonise the sector.”

WASE were successful in securing grant funding through RAIA and Dr Johnathan Matlock, co-founder of Science Angel Syndicate, comments: “Developing new hardware solutions is risky and the timelines to maturity are often longer than in other industries. Grant funding is a critical mechanism to support angel investors who are investing in innovative companies like WASE. By leveraging the private investment with non-dilutive grant funding we think this will enable WASE to continue the development of the next generation of electrodes and improve performance even further.”